Description
Pulmicort Suspension for Inhalation 0.25 mg/ml. 2 ml. №20
Ingredients
- Active ingredient: Budesonide
- Inactive ingredients: Disodium edetate, sodium chloride, hydrochloric acid, and purified water
Dosage
Dosage: The usual dose is 0.5 to 1 mg twice daily. The maximum daily dose should not exceed 2 mg twice daily.
Indications
Indications: Pulmicort is indicated for the maintenance treatment of asthma as prophylactic therapy in adults and children.
Contraindications
Contraindications: Do not use Pulmicort in patients with known hypersensitivity to budesonide or any of the ingredients.
Directions
Directions: Administer by inhalation using a suitable nebulizer. Rinse mouth with water after each use to prevent oral fungal infections.
Scientific Evidence
Scientific evidence: Studies have shown that budesonide, the active ingredient in Pulmicort, effectively reduces airway inflammation and improves lung function in asthma patients (Source: Global Initiative for Asthma).
Additional Information
- Storage: Store at room temperature away from moisture and heat. Do not freeze. Once opened, use within 2 weeks.
- Pharmacological Effects: Budesonide, a corticosteroid, exerts its anti-inflammatory action by inhibiting the release of inflammatory mediators and reducing the infiltration of inflammatory cells in the airways. This helps to decrease airway hyperresponsiveness and improve asthma symptoms.
- Clinical Trials: Clinical trials have demonstrated the efficacy of Pulmicort in reducing asthma exacerbations, improving lung function, and enhancing quality of life in patients with persistent asthma. In a randomized controlled trial published in the Journal of Allergy and Clinical Immunology, Pulmicort was found to significantly reduce the rate of severe asthma exacerbations compared to placebo.
